Incident and Prevalent Use of Alvimopan, Naltrexone, and Methylnaltrexone

Project Title Incident and Prevalent Use of Alvimopan, Naltrexone, and Methylnaltrexone
Date Posted
Sunday, November 23, 2014
Project ID
msy5_str004, msy5_str005
Status
In progress
Deliverables
Description

Summary table assessment of the incident and prevalent use of six generic drug products: Alvimopan, Methylnaltrexone Bromide, Morphine Sulfate/Naltrexone, Naltrexone, Naltrexone HCL, and Naltrexone Microspheres. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed on October 24, 2013. This report includes data from 17 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
alvimopan
methylnaltrexone bromide
morphine sulfate/naltrexone
naltrexone
naltrexone HCL
naltrexone microsphere
Time Period
2001-2013
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top